Cetera Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.05M Buy
2,608
+1,614
+162% +$567K 0.01% 1133
2023
Q4
$305K Sell
994
-385
-28% -$104K ﹤0.01% 1414
2023
Q3
$334K Sell
1,379
-160
-10% -$40.9K 0.01% 1269
2023
Q2
$370K Buy
1,539
+131
+9% +$27.2K 0.01% 1193
2023
Q1
$265K Sell
1,408
-29
-2% -$6K ﹤0.01% 1345
2022
Q4
$305K Buy
+1,437
New +$287K 0.01% 1231

Other funds holding MEDP

Cetera Advisors's MEDP Position: Q1 2024 in Review

Cetera Advisors increased its Medpace (MEDP) stake by 162% in Q1 2024, buying an estimated $567K and bringing the position to 2,608 shares worth $1.05M. The position accounts for 0.01% of the portfolio, ranked #1133.

Cetera Advisors first reported a position in MEDP in Q4 2022 and has held it in 6 quarters since. 597 funds tracked by Wall St. Rank hold MEDP as of Q1 2024.

  • Cetera Advisors held 2,608 shares of Medpace worth $1.05M as of Q1 2024.
  • Cetera Advisors bought 1,614 Medpace shares in Q1 2024, an estimated $567K.
  • Medpace made up 0.01% of Cetera Advisors's portfolio in Q1 2024, its #1133 holding.
  • Cetera Advisors first reported a position in Medpace in Q4 2022 and has held it in 6 quarters since.
  • 597 funds tracked by Wall St. Rank held Medpace as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.